Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma
- 1 November 1996
- Vol. 78 (9), 1888-1891
- https://doi.org/10.1002/(sici)1097-0142(19961101)78:9<1888::aid-cncr7>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Triazinate and Platinum Efficacy in Combination With 5-Fluorouracil and Doxorubicin: Results of a Three-Arm Randomized Trial in Metastatic Gastric CancerJNCI Journal of the National Cancer Institute, 1988
- An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.Journal of Clinical Oncology, 1987
- Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.Journal of Clinical Oncology, 1986
- Chemotherapy for advanced pancreatic cancer.A comparison of 5-fluorouracil, adriamycin, and mitomycin (fam) with 5-fluorouracil, streptozotocin, and mitomycin (fsm)Cancer, 1986
- Randomized study of combination chemotherapy in unresectable gastric cancerCancer, 1984
- A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinomaCancer, 1982
- 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreasCancer, 1980
- 5-fluorouracil, adriamycin, and mitomycin-c (fam) combination chemotherapy in the treatment of advanced gastric cancerCancer, 1979
- Sequential and combination chemotherapy of advanced gastric cancerCancer, 1976
- A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancerCancer, 1974